Surely we are nearing the completion of the trial... Or at least close enough that they can stop recruiting and progress to the next stage.
Unfortunately there are over 20,000 new cases of breast cancer in Australia each year equating to 57 per day. 15-20% of these cases are HER2-positive resulting in roughly 4,000 potential patients annually just in Australia. Surely it shouldn't be too hard to enrol 15 participants...
The lack of news is painful for us shareholders, but more-so for current and future breast cancer patients. With the potential life saving technology here you'd think that they want to finish the trials ASAP.
At least we do know that:
- It's safe
- It reaches the patients lymph nodes
- It has multiple purposes
C'mon Bob please give everyone an early Christmas present this year!
- Forums
- ASX - By Stock
- IBX
- [VIDEO] Imagion Biosystems (ASX:IBX) finds that diagnostic tech has potential to work on multiple cancers
[VIDEO] Imagion Biosystems (ASX:IBX) finds that diagnostic tech has potential to work on multiple cancers, page-80
Featured News
Add IBX (ASX) to my watchlist
(20min delay)
|
|||||
Last
4.5¢ |
Change
0.004(9.76%) |
Mkt cap ! $1.604M |
Open | High | Low | Value | Volume |
4.5¢ | 4.6¢ | 4.5¢ | $4.008K | 87.80K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 57624 | 4.3¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
4.6¢ | 48125 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 57624 | 0.043 |
1 | 100000 | 0.042 |
2 | 32464 | 0.041 |
3 | 223500 | 0.040 |
1 | 128205 | 0.039 |
Price($) | Vol. | No. |
---|---|---|
0.046 | 48125 | 2 |
0.047 | 14800 | 1 |
0.048 | 1016 | 1 |
0.050 | 1500 | 1 |
0.055 | 88714 | 1 |
Last trade - 13.38pm 21/10/2024 (20 minute delay) ? |
Featured News
IBX (ASX) Chart |
The Watchlist
LGP
LITTLE GREEN PHARMA LTD
Paul Long, Chief Executive Officer
Paul Long
Chief Executive Officer
SPONSORED BY The Market Online